CD163 and lung carcinoma: We also observed the presence of Ki-67+ CD163+ TAMs in tumours from patients with primary and metastatic breast cancer and lung cancer (Supplementary Figures 1B, C), suggesting proliferating TAMs contribute to the accumulation of TAMs in many cancer types.